Nutra Pharma widens homeopathic pain reliever distribution
This article was originally published in The Tan Sheet
Executive Summary
The Plantation, Fla.-based manufacturer will register its new homeopathic pain reliever Cobroxin for over-the-counter sales in Canada and Europe, according to a Sept. 21 release. NutraPharma claims Cobroxin is the first OTC product to treat moderate to severe chronic pain. The cobra venom-based oral spray and topical gel launched in the U.S. in August and will be available in drugstores soon, according to its Web site. XenaCare Holding has the exclusive U.S. marketing and distribution rights for Cobroxin
|
The Plantation, Fla.-based manufacturer will register its new homeopathic pain reliever Cobroxin for over-the-counter sales in Canada and Europe, according to a Sept. 21 release. NutraPharma claims Cobroxin is the first OTC product to treat moderate to severe chronic pain. The cobra venom-based oral spray and topical gel launched in the U.S. in August and will be available in drugstores soon, according to its Web site. XenaCare Holding has the exclusive U.S. marketing and distribution rights for Cobroxin. |